Literature DB >> 24034549

Diffusion-weighted MRI of hepatocellular carcinoma in cirrhosis.

K S Lim1.   

Abstract

The internationally accepted diagnostic criteria for hepatocellular carcinoma (HCC) in cirrhosis are highly accurate for large tumours, but offer relatively low sensitivity for small (<2 cm) tumours. Diffusion-weighted imaging (DWI) is a functional magnetic resonance imaging (MRI) technique that has been studied extensively as an aid to visualize various abdominal malignancies, including HCC in cirrhosis. DWI maps water diffusivity, which in HCC may be restricted as a result of changes ensuing from hepatocarcinogenesis. The present review is based on up-to-date evidence and describes the strengths and weaknesses of DWI, both as a standalone technique and as an adjunct sequence to conventional protocols, in the diagnosis, staging, prognostication, and assessment of treatment response of HCC in cirrhosis.
Copyright © 2013 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24034549     DOI: 10.1016/j.crad.2013.07.022

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  17 in total

1.  Comparison of diffusion-weighted imaging and T2-weighted single shot fast spin-echo: Implications for LI-RADS characterization of hepatocellular carcinoma.

Authors:  Robert M Hicks; Judy Yee; Michael A Ohliger; Stefanie Weinstein; Jeffrey Kao; Nabia S Ikram; Thomas A Hope
Journal:  Magn Reson Imaging       Date:  2016-04-21       Impact factor: 2.546

2.  Histological grade of hepatocellular carcinoma predicted by quantitative diffusion-weighted imaging.

Authors:  Weihua Guo; Suhong Zhao; Yuhai Yang; Guangrui Shao
Journal:  Int J Clin Exp Med       Date:  2015-03-15

Review 3.  Diffusion-weighted MRI of the liver: challenges and some solutions for the quantification of apparent diffusion coefficient and intravoxel incoherent motion.

Authors:  Yi Xiang J Wang; Hua Huang; Cun-Jing Zheng; Ben-Heng Xiao; Olivier Chevallier; Wei Wang
Journal:  Am J Nucl Med Mol Imaging       Date:  2021-04-15

4.  Role of diffusion-weighted imaging, apparent diffusion coefficient and correlation with hepatobiliary phase findings in the differentiation of hepatocellular carcinoma from dysplastic nodules in cirrhotic liver.

Authors:  Riccardo Inchingolo; Anna Maria De Gaetano; Davide Curione; Marzia Ciresa; Luca Miele; Maurizio Pompili; Fabio Maria Vecchio; Felice Giuliante; Lorenzo Bonomo
Journal:  Eur Radiol       Date:  2014-11-28       Impact factor: 5.315

Review 5.  Prognostication and response assessment in liver and pancreatic tumors: The new imaging.

Authors:  Riccardo De Robertis; Paolo Tinazzi Martini; Emanuele Demozzi; Gino Puntel; Silvia Ortolani; Sara Cingarlini; Andrea Ruzzenente; Alfredo Guglielmi; Giampaolo Tortora; Claudio Bassi; Paolo Pederzoli; Mirko D'Onofrio
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

Review 6.  Diffusion-weighted imaging of the liver: techniques and applications.

Authors:  Sara Lewis; Hadrien Dyvorne; Yong Cui; Bachir Taouli
Journal:  Magn Reson Imaging Clin N Am       Date:  2014-08       Impact factor: 2.266

7.  Preoperative evaluation of the histological grade of hepatocellular carcinoma with diffusion-weighted imaging: a meta-analysis.

Authors:  Jie Chen; Mingpeng Wu; Rongbo Liu; Siyi Li; Ronghui Gao; Bin Song
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

Review 8.  Contrast Enhanced MRI in the Diagnosis of HCC.

Authors:  Eric Niendorf; Benjamin Spilseth; Xiao Wang; Andrew Taylor
Journal:  Diagnostics (Basel)       Date:  2015-09-21

Review 9.  Imaging of HCC-Current State of the Art.

Authors:  Christina Schraml; Sascha Kaufmann; Hansjoerg Rempp; Roland Syha; Dominik Ketelsen; Mike Notohamiprodjo; Konstantin Nikolaou
Journal:  Diagnostics (Basel)       Date:  2015-11-27

10.  Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol.

Authors:  Hyun A Kim; Kyung Ah Kim; Joon-Il Choi; Jeong Min Lee; Chang Hee Lee; Tae Wook Kang; Young-Mi Ku; Su Lim Lee; Yang Shin Park; Jeong Hee Yoon; Seong Hyun Kim; Moon Hyung Choi
Journal:  BMC Cancer       Date:  2017-12-21       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.